Contract 36F79720D0156
Indivior Inc. · Department Of Veterans Affairs · June 24, 2024
Indivior Inc. was awarded a federal contract by Department Of Veterans Affairs on June 24, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 26, 2026. If all options are exercised, the contract could reach $131.88 million.
Contract details
- PIID
- 36F79720D0156
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- June 24, 2024
- Latest action
- February 26, 2026
Description
ADMIN CHANGE - POC
Modification timeline
-
February 26, 2026Mod P00031 · Supplemental Agreement For Work Within Scope$0
-
December 18, 2025Mod P00030 · Supplemental Agreement For Work Within ScopeTPR ALL FSS USERS$0
-
December 3, 2025Mod P00029 · Supplemental Agreement For Work Within Scope2026 PUBLIC LAW$0
-
November 21, 2025Mod P00028 · Supplemental Agreement For Work Within ScopeTC CHANGE$0
-
June 24, 2024Mod P00020 · Supplemental Agreement For Work Within ScopeLIFE CYCLE CHANGE$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79720D0156?
Contract 36F79720D0156 is a federal contract awarded to Indivior Inc. by Department Of Veterans Affairs on June 24, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79720D0156?
Indivior Inc. won contract 36F79720D0156 from Department Of Veterans Affairs.
How much is contract 36F79720D0156 worth?
Contract 36F79720D0156 has obligated $0 to date but carries a potential ceiling of $131.88 million if fully funded and all options are exercised.